Literature DB >> 15268730

Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?

Herwig-Ulf Meier-Kriesche1, Jesse D Schold, Bruce Kaplan.   

Abstract

Impressive renal allograft survival improvement between 1988 and 1995 has been described using projections of half-lives based on limited actual follow up. We aimed, now with sufficient follow up available to calculate real half-lives. Real half-lives calculated from Kaplan-Meier curves for the overall population as well as subsets of repeat transplants and African Americans recipients were examined. Real half-lives were substantially shorter than projected half-lives. As a whole, half-lives have improved by about 2 years between 1988 and 1995 as compared to the earlier projected 6 years of improvement. The improvement seems to be driven primarily by the improvement in graft survival of re-transplants. First transplants showed a cumulative increase in graft survival of less than 6 months. Projected half-lives are a risky estimation of long-term survival especially when based on short actual follow up. First transplant survival has only marginally improved during the early years of post transplant follow up while no significant improvement in long-term survival could be detected between 1988 and 1995. Redirection of attention from early endpoints towards the process of long-term graft loss may be necessary to sustain early gains in the long term.

Mesh:

Year:  2004        PMID: 15268730     DOI: 10.1111/j.1600-6143.2004.00515.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  137 in total

Review 1.  Assessment of kidney organ quality and prediction of outcome at time of transplantation.

Authors:  Thomas F Mueller; Kim Solez; Valeria Mas
Journal:  Semin Immunopathol       Date:  2011-01-28       Impact factor: 9.623

Review 2.  B cells and transplantation tolerance.

Authors:  Allan D Kirk; Nicole A Turgeon; Neal N Iwakoshi
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

3.  Kidney and recipient weight incompatibility reduces long-term graft survival.

Authors:  Magali Giral; Yohann Foucher; Georges Karam; Yann Labrune; Michelle Kessler; Bruno Hurault de Ligny; Mathias Büchler; François Bayle; Carole Meyer; Nathalie Trehet; Pascal Daguin; Karine Renaudin; Anne Moreau; Jean Paul Soulillou
Journal:  J Am Soc Nephrol       Date:  2010-05-20       Impact factor: 10.121

Review 4.  Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits.

Authors:  Renaud Snanoudj; Julien Zuber; Christophe Legendre
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

5.  Gazing into a crystal ball to predict kidney transplant outcome.

Authors:  Bernd Schröppel; Peter S Heeger
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

6.  Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.

Authors:  Darshika Chhabra; Anton I Skaro; Joseph R Leventhal; Pranav Dalal; Gaurav Shah; Edward Wang; Lorenzo Gallon
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

7.  Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.

Authors:  Daniel E Weiner; Meyeon Park; Hocine Tighiouart; Alin A Joseph; Myra A Carpenter; Nitender Goyal; Andrew A House; Chi-Yuan Hsu; Joachim H Ix; Paul F Jacques; Clifton E Kew; S Joseph Kim; John W Kusek; Todd E Pesavento; Marc A Pfeffer; Stephen R Smith; Matthew R Weir; Andrew S Levey; Andrew G Bostom
Journal:  Am J Kidney Dis       Date:  2018-07-20       Impact factor: 8.860

Review 8.  T Follicular Regulatory Cells and Antibody Responses in Transplantation.

Authors:  Elizabeth F Wallin
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

9.  Graft-Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection.

Authors:  C Wu; Y Zhao; X Xiao; Y Fan; M Kloc; W Liu; R M Ghobrial; P Lan; X He; X C Li
Journal:  Am J Transplant       Date:  2016-05-02       Impact factor: 8.086

10.  Quantitative patterns of azathioprine adherence after renal transplantation.

Authors:  Thomas E Nevins; William Thomas
Journal:  Transplantation       Date:  2009-03-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.